Ozturk, Arinc
Grajo, Joseph R.
Dhyani, Manish
Anthony, Brian W.
Samir, Anthony E.
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (HHSN268201300071 C, K23 EB020710)
Article History
First Online: 27 February 2018
Compliance with ethical standards
:
: Anthony E. Samir’s effort was funded by the NIBIB of the National Institutes of Health under award numbers HHSN268201300071 C and K23 EB020710.
: Anthony E. Samir has received research grants or support from Supersonic Imagine, General Electric, Philips, Toshiba Medical Systems, Hitachi Medical Systems, and Siemens Healthineers. He has also received speaker honoraria from Supersonic Imagine and General Electric and has received consulting fees in related domains from General Electric, Pfizer, Novartis, Bristol Myers Squibb, Jazz Pharmaceuticals, and Parexel. He is a member of the Quantitative Imaging Biomarkers Alliance (QIBA) clinical ultrasound elastography Task Force and is imaging co-chair of the Foundation for the National Institutes of Health Noninvasive Biomarkers of Metabolic Liver Disease (NIMBLE) Biomarkers consortium. He declares no conflict of interest between these various roles and the content of this paper.
: This article does not contain any studies with human participants or animals performed by any of the authors.